| Application no. and date | 18746457.3 (espacenet) (Federated) (European Patent Register), 20180709 | | Patent/reg. no. and date | DK/EP 3648787, 20241030 | | Publication date | 20200513 | | Priority no. and date | US 201762530024 P, 20170707, US 201762546999 P, 20170817 | | EP pub. no. and date |
EP 3648787 20200513 | | Effective date | | | Applicant/owner | Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome,
Chuo-ku,
Osaka-shi, Osaka, JP | | Applicant ref. no. | P85517DK01 | | Inventor | EWENSTEIN, Bruce, 15 Claflin Path
Brookline, MA 02445, US,
CHAPMAN, Miranda, 55 High Ledge Ave.
Wellesley, MA 02482, US,
PLODER, Bettina, Am Kaisermühlendamm 107/3/301
1220 Vienna, AT | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 38/36 (2006.01) , A61P 7/04 (2006.01) | | Title | BEHANDLING AF PATIENTER, DER HAR SVÆR VON WILLEBRAND-SYGDOM OG FÅR FORETAGET ELEKTIV KIRURGI,
VED ADMINISTRATION AF REKOMBINANT VWF | | Int. application no. | US2018041319 | | Int. publication no. | WO2019010496 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
